Von Willebrand factor: molecular size and functional activity M. Furlan REVIEW ARTICLE Pages: 341 - 348
Interferon alpha-2c therapy of patients with chronic myelogenous leukemia: long-term results of a multicenter phase-II study J. ThalerG. GastlAustrian Biological Response Modifier (BRM) Study Group* ORIGINAL ARTICLE Pages: 349 - 355
Hodgkin's disease presenting as a cholestatic febrile illness: incidence and main characteristics in a series of 421 patients F. CervantesJ. BrionesE. Montserrat ORIGINAL ARTICLE Pages: 357 - 360
Assessment of the composition of bone marrow prior to and following autologous BMT and PBSCT by magnetic resonance F. SchickH. EinseleC. D. Claussen ORIGINAL ARTICLE Pages: 361 - 370
A long-lasting, complete hematologic and cytogenetic remission of chronic myelogenous leukemia after treatment with busulfan alone C. M. P. W. MandigersE. J. B. M. MensinkT. de Witte CASE REPORT Pages: 371 - 373
Co-expression of two FAB-specific chromosome changes, t(15; 17) and t(8; 21), in a case of acute promyelocytic leukemia A. MovafaghN. VarmaS. Varma CASE REPORT Pages: 375 - 377
Radiotherapy combined with erythropoietin for the treatment of extramedullary hematopoiesis in an alloimmunized patient with thalassemia intermedia P. CianciulliF. SorrentinoS. Amadori CASE REPORT Pages: 379 - 381
Acquired C 1-inhibitor deficiency with angioedema due to pleomorphic immunocytoma in a patient with three malignant tumors: long-term follow-up data and presentation of an additional case W. BohleU. RütherP. Jipp CASE REPORT Pages: 383 - 386
